0001493152-16-006599.txt : 20160105
0001493152-16-006599.hdr.sgml : 20160105
20160105140616
ACCESSION NUMBER: 0001493152-16-006599
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150109
FILED AS OF DATE: 20160105
DATE AS OF CHANGE: 20160105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences Inc
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knox Thomas J
CENTRAL INDEX KEY: 0001520356
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 161321478
MAIL ADDRESS:
STREET 1: 1717 ARCH STREET
STREET 2: SUITE 3820
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4/A
1
form4a.xml
X0306
4/A
2015-01-09
2015-01-09
0
0001321834
Akers Biosciences Inc
AKER
0001520356
Knox Thomas J
50 S. 16TH STREET
PHILADELPHIA
PA
19102
1
0
0
0
Common Stock
2015-01-09
4
A
0
50000
0
A
408150
D
Such shares were issued under Akers Biosciences, Inc.'s Amended and Restated 2013 Incentive Stock and Award Plan.
The Form 4 filed on January 12, 2015 for Mr. Knox incorrectly listed the amount of common stock beneficially owned as 466,666. At such time, Mr. Knox beneficially owned 408,150 shares of common stock. This amended Form 4 represents the correct total amount of common stock beneficially owned by Mr. Knox as of January 12, 2015.
/s/ Thomas J. Knox
2016-01-05